In the last trading session, 22.66 million shares of the GlucoTrack Inc (NASDAQ:GCTK) were traded, and its beta was -0.11. Most recently the company’s share price was $0.18, and it changed around $0.01 or 9.31% from the last close, which brings the market valuation of the company to $4.72M. GCTK currently trades at a discount to its 52-week high of $79.00, offering almost -43788.89% off that amount. The share price’s 52-week low was $0.13, which indicates that the current value has risen by an impressive 27.78% since then.

GlucoTrack Inc (NASDAQ:GCTK) trade information

Instantly GCTK has showed a green trend with a performance of 9.31% at the end of last trading. The performance over the last five days has remained in the green territory. The rise to weekly highs of 0.2085 on recent trading dayincreased the stock’s daily price by 13.67%. The company’s shares are currently down -97.53% year-to-date, but still up 5.98% over the last five days. On the other hand, GlucoTrack Inc (NASDAQ:GCTK) is -1.39% down in the 30-day period.

Looking at the company’s year-over-year earnings, the past five years showed a negative earnings growth rate of -18.33%.

GCTK Dividends

GlucoTrack Inc’s next quarterly earnings report is expected to be released in June.

Fidelity Concord Street Trust-Fidelity Extended Market Index Fund and Fidelity Concord Street Trust-Fidelity Series Total Market Index Fund were the top two Mutual Funds as of Feb 28, 2025 . The former held 1.08 shares worth $199.0, making up 0.00% of all outstanding shares. On the other hand, Fidelity Concord Street Trust-Fidelity Series Total Market Index Fund held roughly 243.0 shares worth around $44.0, which represents about 0.00% of the total shares outstanding.